{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:11:57Z","timestamp":1767143517376,"version":"build-2238731810"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["SP\/19\/3\/34678"],"award-info":[{"award-number":["SP\/19\/3\/34678"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The severe acute respiratory syndrome  coronavirus 2 (SARS-CoV-2) virus (coronavirus disease 2019 [COVID-19]) pandemic revealed the vulnerability of specific population groups in relation to susceptibility to acute deterioration in their health, including hospital admission and mortality. There is less data on outcomes for people with type 1 diabetes (T1D) following SARS-CoV-2 infection than for those with type 2 diabetes (T2D). In this study we set out to determine the relative likelihood of hospital admission following SARS-CoV-2 infection in people with T1D when compared to those without T1D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study was conducted as a retrospective cohort study and utilised an all-England dataset. Electronic health record data relating to people in a national England database (NHS England\u2019s Secure Data Environment, accessed via the BHF Data Science Centre's CVD-COVID-UK\/COVID-IMPACT consortium) were analysed. The cohort consisted of patients with a confirmed SARS-CoV-2 infection, and the exposure was whether or not an individual had T1D prior to infection (77,392 patients with T1D). The patients without T1D were matched for sex, age and approximate date of the positive COVID-19 test, with three SARS-CoV-2-infected people living without diabetes (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009223,995). Potential factors influencing the relative likelihood of the outcome of hospital admission within 28\u00a0days were ascertained using univariable and multivariable logistic regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Median age of the people living with T1D was 37 (interquartile range 25\u201352) years, 47.4% were female and 89.6% were of white ethnicity. Mean body mass index was 27 (standard error [SE] 0.022)\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , and mean glycated haemoglobin (HbA1c) was 67.3 (SE 0.069) mmol\/mol (8.3%). A significantly higher proportion of people with T1D (10.7%) versus matched non-diabetes individuals (3.9%) were admitted to hospital. In combined analysis including individuals with T1D and matched controls, multiple regression modelling indicated that the factors independently relating to a higher likelihood of hospital admission were: T1D (odds ratio [OR] 1.71, 95% confidence interval [CI] 1.62\u20131.80]), age (OR 1.02, 95% CI 1.02\u20131.03), social deprivation (higher Townsend deprivation score: OR 1.07, 95% CI 1.06\u20131.08), lower estimated glomerular filtration rate (eGFR) value (OR 0.975, 95% CI 0.974\u20130.976), non-white ethnicity (OR black 1.19, 95% CI 1.06\u20131.33\/OR Asian 1.21, 95% CI 1.05\u20131.39) and having asthma (OR 1.27, 95% CI 1.19\u20131.35]), chronic obstructive pulmonary disease (OR 2.10, 95% CI 1.89\u20132.32), severe mental illness (OR 1.83, 95% CI 1.57\u20132.12) or hypertension (OR 1.44, 95% CI 1.37\u20131.52).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this all-England study, we describe that, following confirmed infection with SARS-CoV-2, the risk factors for hospital admission for people living with T1D are similar to people without diabetes following confirmed SARS-CoV-2 infection, although the former were more likely to be admitted to hospital. The younger age of individuals with T1D in relation to risk stratification must be taken into account in any ongoing risk reduction strategies regarding COVID-19\/future viral pandemics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s13300-023-01456-8","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T22:01:42Z","timestamp":1692914502000},"page":"2031-2042","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9537-4050","authenticated-orcid":false,"given":"Adrian H.","family":"Heald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajshekhar N.","family":"Mudaliar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akheel","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Naseem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Bowden-Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Martin","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Ollier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the CVD-COVID-UK\/COVID-IMPACT Consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"1456_CR1","unstructured":"World Health Organization. Coronavirus disease (COVID-19). https:\/\/www.who.int\/health-topics\/coronavirus. Accessed 24 July 2022."},{"key":"1456_CR2","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s00125-020-05164-x","volume":"63","author":"P Katulanda","year":"2020","unstructured":"Katulanda P, Dissanayake HA, Ranathunga I, et al. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature. Diabetologia. 2020;63:1440\u201352.","journal-title":"Diabetologia"},{"key":"1456_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","volume":"8","author":"E Barron","year":"2020","unstructured":"Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8:813\u201322.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1456_CR4","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s13300-022-01230-2","volume":"13","author":"AH Heald","year":"2022","unstructured":"Heald AH, Jenkins DA, Williams R, et al. The risk factors potentially influencing hospital admission in people with diabetes, following SARS-CoV-2 infection: a population-level analysis. Diabetes Ther. 2022;13:1007\u201321.","journal-title":"Diabetes Ther"},{"issue":"73","key":"1456_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-med-042220-011857","volume":"27","author":"AK Singh","year":"2022","unstructured":"Singh AK, Khunti K. COVID-19 and diabetes. Annu Rev Med. 2022;27(73):129\u201347.","journal-title":"Annu Rev Med"},{"key":"1456_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s13300-022-01259-3","volume":"13","author":"AH Heald","year":"2022","unstructured":"Heald AH, Jenkins DA, Williams R, . Mortality in people with type 2 diabetes following SARS-CoV-2 infection: a population level analysis of potential risk factors. Diabetes Ther. 2022;13:1037\u201351.","journal-title":"Diabetes Ther"},{"key":"1456_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2244","volume":"374","author":"J Hippisley-Cox","year":"2021","unstructured":"Hippisley-Cox J, Coupland CA, Mehta N, et al. Risk prediction of COVID-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study. BMJ. 2021;374: n2244.","journal-title":"BMJ"},{"key":"1456_CR8","unstructured":"Health Data Research UK. Project\nCVD-COVID-UK\/COVID-IMPACT. https:\/\/bhfdatasciencecentre.org\/areas\/cvd-covid-uk-covid-impact\/. Accessed 15 Mar 2023."},{"key":"1456_CR9","unstructured":"NHS Digital. Hospital episode statistics (HES). https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics. Accessed 20 Mar 2023."},{"key":"1456_CR10","unstructured":"NHS Digital. General Practice Extraction Service (GPES). https:\/\/digital.nhs.uk\/services\/general-practice-extraction-service. Accessed 20 Mar 2023."},{"issue":"Suppl 2","key":"1456_CR11","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1136\/jech.49.Suppl_2.S30","volume":"49","author":"SA Dolan","year":"1995","unstructured":"Dolan SA, Jarman B, Bajekal M, Davies PM, Hart D. Measuring disadvantage: changes in the underprivileged area, Townsend, and Carstairs scores 1981\u201391. J Epidemiol Community Health. 1995;49(Suppl 2):S30\u20133.","journal-title":"J Epidemiol Community Health"},{"key":"1456_CR12","doi-asserted-by":"crossref","unstructured":"Vangoitsenhoven R, Martens P-J, van Nes F, et al. No evidence of increased hospitalization rate for COVID-19 in community-dwelling patients with type 1 diabetes. Diabetes Care. 2020;43:e118\u20139.","DOI":"10.2337\/dc20-1246"},{"key":"1456_CR13","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.2337\/dc20-1540","volume":"43","author":"M Vamvini","year":"2020","unstructured":"Vamvini M, Lioutas VA, Middelbeek RJW. Characteristics and diabetes control in adults with type 1 diabetes admitted with COVID-19 infection. Diabetes Care. 2020;43:e120\u20132.","journal-title":"Diabetes Care"},{"issue":"1","key":"1456_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.dsx.2021.02.009","volume":"15","author":"M Nassar","year":"2021","unstructured":"Nassar M, Nso N, Baraka B, et al. The association between COVID-19 and type 1 diabetes mellitus: a systematic review. Diabetes Metab Syndr. 2021;15(1):447\u201354.","journal-title":"Diabetes Metab Syndr"},{"key":"1456_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","volume":"8","author":"N Holman","year":"2020","unstructured":"Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8:823\u201333.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1456_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2337\/diacare.23.1.95","volume":"23","author":"SA Smith","year":"2000","unstructured":"Smith SA, Poland GA. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care. 2000;23:95\u2013108.","journal-title":"Diabetes Care"},{"key":"1456_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.dsx.2021.02.026","volume":"15","author":"R Pal","year":"2021","unstructured":"Pal R, Bhadada SK, Misra A. COVID-19 vaccination in patients with diabetes mellitus: current concepts, uncertainties and challenges. Diabetes Metab Syndr. 2021;15:505\u20138.","journal-title":"Diabetes Metab Syndr"},{"key":"1456_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s13300-022-01338-5","volume":"14","author":"AH Heald","year":"2023","unstructured":"Heald AH, Jenkins DA, Williams R, et al. COVID-19 vaccination and diabetes mellitus: how much has it made a difference to outcomes following confirmed COVID-19 infection? Diabetes Ther. 2023;14:193\u2013204.","journal-title":"Diabetes Ther"},{"key":"1456_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13528","volume":"74","author":"M Stedman","year":"2020","unstructured":"Stedman M, Davies M, Lunt M, Verma A, Anderson SG, Heald AH. A phased approach to unlocking during the COVID-19 pandemic-Lessons from trend analysis. Int J Clin Pract. 2020;74: e13528.","journal-title":"Int J Clin Pract"},{"key":"1456_CR20","doi-asserted-by":"crossref","unstructured":"Office for Official Statistics. Census 2021.\nData and analysis from Census 2021. https:\/\/www.ons.gov.uk. Accessed 12 Mar 2023.","DOI":"10.34123\/icdsos.v2021i1.25"}],"updated-by":[{"DOI":"10.1007\/s13300-023-01483-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000}}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-023-01456-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-023-01456-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-023-01456-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T14:10:38Z","timestamp":1698156638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-023-01456-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1007\/s13300-023-01456-8","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]},"assertion":[{"value":"14 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13300-023-01483-5","URL":"https:\/\/doi.org\/10.1007\/s13300-023-01483-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}